Creative Biolabs Expands Comprehensive Solutions to Advance CAR‑T Therapy Research
Creative Biolabs introduces CAR-T therapy research solutions and webinars to help scientists drive innovation in CAR-T development.
Creative Biolabs, the world's leading biotechnological solutions provider, today announces its new comprehensive portfolio of solutions to accelerate chimeric antigen receptor T-cell (CAR-T) research. Through its industry-leading platforms, expert scientist guidance and educational webinars, Creative Biolabs is dedicated to helping scientists and research organizations solve technical challenges and drive innovation in CAR-T development.
